Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

MNPR holding history

Monopar Therapeutics in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overviewAll 13F holders of MNPRFull Q4 2025 holdings

Shares (Q4 2025)
293,816
Value
$19.2M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of MNPR by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025293,816$19.2M<0.1%+85,598+41.1%AddedHolders
Q3 2025208,218$17.0M<0.1%+121,729+140.7%AddedHolders
Q2 202586,489$3.09M<0.1%+31,255+56.6%AddedHolders
Q1 202555,234$2.01M<0.1%−1,275−2.3%ReducedHolders
Q4 202456,509$1.24M<0.1%+56,509NewHolders
Q3 20240$00.0%−9,033−100.0%Sold outConverted for a 1-for-5 splitHolders
Q2 202445,167$33.0K<0.1%00.0%UnchangedHolders
Q1 202445,167$30.8K<0.1%00.0%UnchangedHolders
Q4 202345,167$15.4K<0.1%−42,429−48.4%ReducedHolders
Q3 202387,596$54.3K<0.1%−11,580−11.7%ReducedHolders
Q2 202399,176$84.8K<0.1%−800−0.8%ReducedHolders
Q1 202399,976$139.0K<0.1%00.0%UnchangedHolders
Q4 202299,976$236.9K<0.1%+97+0.1%AddedHolders
Q3 202299,879$152.0K<0.1%00.0%UnchangedHolders
Q2 202299,879$230.0K<0.1%00.0%UnchangedHolders
Q1 202299,879$255.0K<0.1%00.0%UnchangedHolders
Q4 202199,879$321.0K<0.1%00.0%UnchangedHolders
Q3 202199,879$487.0K<0.1%+2,417+2.5%AddedHolders
Q2 202197,462$574.0K<0.1%+52,392+116.2%AddedHolders
Q1 202145,070$279.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.